Epiretinal Membranes Completed Phase Trials for Ranibizumab (DB01270)

Also known as: Epi-retinal Membrane / Epiretinal Membrane / Cellophane maculopathy / Epimacular membrane / Preretinal fibrosis / Macular puckering / Epiretinal membrane (morphologic abnormality) / Epiretinal membrane (disorder) / Macular puckering of retina

IndicationStatusPhase
DBCOND0037992 (Epiretinal Membranes)CompletedNot Available
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT01238393Treatment of Epiretinal Membranes With RanibizumabTreatment